Jeff Davis - Providence Business News

Home Tags Jeff Davis

FAR REACH: Avidex Industries LLC serves clients worldwide. From left, Bob Mathews, senior account executive; Thomas Ward, senior project manager; and Dominique Perrin, project coordinator, work on blueprints in Warwick.  PBN PHOTO /ELIZABETH GRAHAM

Warwick AV firm goes global: Avidex

Industries 09/25/2026

Innovative Companies 2026 Awards TECHNOLOGY: Avidex Industries LLC Avidex INDUSTRIES LLC has been wiring up conference rooms, classrooms and command centers for 27 years. The...

Under pressure to meet Jan. 1 deadline, town planners had a...

Government 12/27/2023

Since last summer, Warwick Planning Director Tom Kravitz has been racing against the clock. That’s why on a recent day he locked himself in...

Grow Smart to host infrastructure investment forum

Financial Services 04/18/2017

PROVIDENCE – Grow Smart Rhode Island, a statewide organization focused on urban planning, is hosting a forum to examine alternative approaches to investing in...

- Featured Event -

Latest News

JOHN MARION became executive director of Providence-based, government watchdog group Common Cause Rhode Island in 2008. / PBN PHOTO/MICHAEL SALERNO

R.I. elections keep adapting

09/25/2026

Warwick AV firm goes global: Avidex

09/25/2026

Attorney-Guided AI: Founding partners John Feeney, left, and Maxwell Holland run Contract House’s flat-rate, attorney-reviewed artificial intelligence law model in Newport.  PBN PHOTO/DAVID HANSEN

Contract House LLC law firm cuts costs with AI

09/25/2026

Reposition has IMG rising

09/25/2026

A REVIVAL: Dr. Annie  De Groot’s cancer vaccine development company in Providence was dormant for several years, but it’s been restarted at an opportune time, when the favorable results of a related clinical trial have given the sector a boost.  PBN PHOTO/MICHAEL SALERNO

Cancer vaccine startup comes back to life

09/25/2026

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.